Original language | English |
---|---|
Pages (from-to) | 1467-1472 |
Number of pages | 6 |
Journal | Blood Advances |
Volume | 1 |
Issue number | 19 |
DOIs | |
State | Published - Aug 22 2017 |
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Blood Advances, Vol. 1, No. 19, 22.08.2017, p. 1467-1472.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - MLL-AF9 leukemias are sensitive to PARP1 inhibitors combined with cytotoxic drugs
AU - Maifrede, Silvia
AU - Martinez, Esteban
AU - Nieborowska-Skorska, Margaret
AU - Marcantonio, Daniela Di
AU - Hulse, Michael
AU - Le, Bac Viet
AU - Zhao, Huaqing
AU - Piwocka, Katarzyna
AU - Tempera, Italo
AU - Sykes, Stephen M.
AU - Skorski, Tomasz
N1 - Funding Information: This work was supported by National Institutes of Health, National Cancer Institute grants R01 CA134458 and CA186238 and the Leukemia and Lymphoma Society New Idea Award NIA-8999-14 (T.S.), and by National Institutes of Health, National Cancer Institute grant R00 CA158461, the W.W. Smith Foundation, and the American Society of Hematology Junior Scholar Award (S.M.S). B.V.L. was supported by the European Union’s Horizon 2020 research and innovation program under Marie Sklodowska-Curie grant agreement no. 665735 and by funding from Polish Ministry of Science and Higher Education for the implementation of international projects, 2016-2020. Funding Information: This work was supported by National Institutes of Health, National Cancer Institute grants R01 CA134458 and CA186238 and the Leukemia and Lymphoma Society New Idea Award NIA-8999-14 (T.S.), and by National Institutes of Health, National Cancer Institute grant R00 CA158461, the W.W. Smith Foundation, and the American Society of Hematology Junior Scholar Award (S.M.S). B.V.L. was supported by the European Union's Horizon 2020 research and innovation program under Marie Sklodowska-Curie grant agreement no. 665735 and by funding from Polish Ministry of Science and Higher Education for the implementation of international projects, 2016-2020.
PY - 2017/8/22
Y1 - 2017/8/22
UR - http://www.scopus.com/inward/record.url?scp=85048282052&partnerID=8YFLogxK
U2 - 10.1182/bloodadvances.2017006247
DO - 10.1182/bloodadvances.2017006247
M3 - Article
AN - SCOPUS:85048282052
SN - 2473-9529
VL - 1
SP - 1467
EP - 1472
JO - Blood Advances
JF - Blood Advances
IS - 19
ER -